Your browser doesn't support javascript.
loading
The Burden of Type 2 Diabetes on the Productivity and Economy in Sub-Saharan Africa: A Life Table Modelling Analysis from a South African Perspective.
Hellebo, Assegid; Kengne, Andre P; Ademi, Zanfina; Alaba, Olufunke.
Afiliación
  • Hellebo A; Health Economics Unit, School of Public Health, Faculty of Health Sciences, University of Cape Town, Observatory, 7925, South Africa. hllass001@myuct.ac.za.
  • Kengne AP; Department of Medicine, University of Cape Town and Non-Communicable Diseases Research Unit, South African Medical Research Council (SAMRC), Francie Van Zijl Dr, Parow Valley, Cape Town, 7501, South Africa.
  • Ademi Z; Health Economics and Policy Evaluation Research (HEPER) Group, Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia.
  • Alaba O; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Pharmacoeconomics ; 42(4): 463-473, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38267807
ABSTRACT
BACKGROUND AND

AIM:

The prevalence of type 2 diabetes (T2D) is rapidly increasing in Sub-Saharan Africa (SSA). T2D increases the risk of premature death and reduces quality of life and work productivity. This population life table modelling analysis evaluated the impact of T2D in terms of productivity-adjusted life years (PALYs) on the South African working-age population. RESEARCH DESIGN AND

METHODS:

Life table modelling was employed to simulate the follow-up of individuals aged 20-65 with T2D in South Africa (SA). Two life table models were developed to simulate health outcomes for a SA cohort with and without diabetes. The difference in the number of deaths, years of life lost (YLL), and PALYs lost between the two cohorts represented the burden of diabetes. Scenarios were simulated in which the proportions of gross domestic productivity (GDP), productivity indices, labour force dropout, and mortality risk trends were adjusted to lower and upper uncertainty bounds. Data were sourced from the International Diabetes Federation, Statistics SA, and both publicly available and published sources. We utilised the World Health Organization (WHO) standard annual discount rate of 3% for YLL and PALYs.

RESULTS:

In 2019, an estimated 9.5% (7.68% men and 11.37% women) or 3.2 million total working-age people had T2D in SA. Simulated follow-up until retirement predicted 669,427 excess mortality, a loss of 6.2 million years of life (9.3%) and 13 million PALYs (30.6%) in SA. On average, this resulted in 3.1 PALYs lost per person. Based on the GDP per full-time employee in 2019, the PALYs loss equated to US$223 billion, or US$69,875 per person.

CONCLUSIONS:

This study emphasises the significant impact of T2D on society and the economy. Relatively modest T2D prevention and treatment management enhancement could lead to substantial economic benefits in SA.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Calidad de Vida / Diabetes Mellitus Tipo 2 Tipo de estudio: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: Pharmacoeconomics Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2024 Tipo del documento: Article País de afiliación: Sudáfrica

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Calidad de Vida / Diabetes Mellitus Tipo 2 Tipo de estudio: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: Pharmacoeconomics Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2024 Tipo del documento: Article País de afiliación: Sudáfrica